446 related articles for article (PubMed ID: 31308203)
1. Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist.
Jamal S; Hudson M; Fifi-Mah A; Ye C
J Rheumatol; 2020 Feb; 47(2):166-175. PubMed ID: 31308203
[TBL] [Abstract][Full Text] [Related]
2. Rheumatologic immune checkpoint inhibitor-related adverse events.
Defoe M; Bermas BL
Curr Opin Rheumatol; 2023 May; 35(3):141-148. PubMed ID: 36912045
[TBL] [Abstract][Full Text] [Related]
3. Rheumatological Adverse Events of Cancer Therapy with Immune Checkpoint Inhibitors.
Cano-Cruz LG; Barrera-Vargas A; Mateos-Soria A; Soto-Perez-de-Celis E; Merayo-Chalico J
Arch Med Res; 2022 Feb; 53(2):113-121. PubMed ID: 34649738
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors and vasculitis.
Boland P; Heath J; Sandigursky S
Curr Opin Rheumatol; 2020 Jan; 32(1):53-56. PubMed ID: 31599800
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitors-related Rheumatic Diseases: What Rheumatologist Should Know?
Gediz F; Kobak S
Curr Rheumatol Rev; 2019; 15(3):201-208. PubMed ID: 30659547
[TBL] [Abstract][Full Text] [Related]
6. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Kostine M; Finckh A; Bingham CO; Visser K; Leipe J; Schulze-Koops H; Choy EH; Benesova K; Radstake TRDJ; Cope AP; Lambotte O; Gottenberg JE; Allenbach Y; Visser M; Rusthoven C; Thomasen L; Jamal S; Marabelle A; Larkin J; Haanen JBAG; Calabrese LH; Mariette X; Schaeverbeke T
Ann Rheum Dis; 2021 Jan; 80(1):36-48. PubMed ID: 32327425
[TBL] [Abstract][Full Text] [Related]
7. Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications.
Cappelli LC; Bingham CO
Arthritis Rheumatol; 2021 Apr; 73(4):553-565. PubMed ID: 33186490
[TBL] [Abstract][Full Text] [Related]
8. [Rheumatological complications of immune checkpoint inhibitor therapy].
Lazarou I; Fernandez E
Rev Med Suisse; 2020 Mar; 16(685):504-507. PubMed ID: 32167253
[TBL] [Abstract][Full Text] [Related]
9. Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update.
Dang QM; Watanabe R; Shiomi M; Fukumoto K; Nobashi TW; Okano T; Yamada S; Hashimoto M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982715
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint inhibitor-associated autoimmunity.
Ladak K; Bass AR
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):781-802. PubMed ID: 31427055
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacist-managed immune checkpoint inhibitor toxicities.
Le S; Chang B; Pham A; Chan A
J Oncol Pharm Pract; 2021 Apr; 27(3):596-600. PubMed ID: 32507100
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.
Xiao Y; Zeng L; Shen Q; Zhou Z; Mao Z; Wang Q; Zhang X; Li Y; Yao W
J Immunol Res; 2020; 2020():2640273. PubMed ID: 32832568
[TBL] [Abstract][Full Text] [Related]
13. Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.
Melissaropoulos K; Klavdianou K; Filippopoulou A; Kalofonou F; Kalofonos H; Daoussis D
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403289
[TBL] [Abstract][Full Text] [Related]
14. Rheumatic immune-related adverse events induced by immune checkpoint inhibitors.
Zhong H; Zhou J; Xu D; Zeng X
Asia Pac J Clin Oncol; 2021 Jun; 17(3):178-185. PubMed ID: 32717098
[TBL] [Abstract][Full Text] [Related]
15. Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management.
Singh N; Shahane A; Sparks JA; Bitoun S; Cappelli LC
Rheum Dis Clin North Am; 2024 May; 50(2):269-279. PubMed ID: 38670725
[TBL] [Abstract][Full Text] [Related]
16. Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology.
Cappelli LC; Shah AA; Bingham CO
Rheum Dis Clin North Am; 2017 Feb; 43(1):65-78. PubMed ID: 27890174
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitor-induced inflammatory arthritis: identification and management.
Williams SG; Mollaeian A; Katz JD; Gupta S
Expert Rev Clin Immunol; 2020 Aug; 16(8):771-785. PubMed ID: 32772596
[TBL] [Abstract][Full Text] [Related]
18. Rheumatological adverse events secondary to immune checkpoint inhibitors.
Garbarino MC; Manzano N; Messina O; Zylberman M
Reumatol Clin (Engl Ed); 2023 Apr; 19(4):215-222. PubMed ID: 37005129
[TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitor Related Rheumatological Complications: Cooperation between Rheumatologists and Oncologists.
Pacholczak-Madej R; Kosałka-Węgiel J; Kuszmiersz P; Mituś JW; Püsküllüoğlu M; Grela-Wojewoda A; Korkosz M; Bazan-Socha S
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981837
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors.
Tocut M; Brenner R; Zandman-Goddard G
Autoimmun Rev; 2018 Jun; 17(6):610-616. PubMed ID: 29631064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]